Today, the Chan Zuckerberg Initiative (CZI) launched the CZI Neurodegeneration Challenge Network. This new network brings together scientists from diverse research fields to understand the underlying causes of neurodegenerative disorders. Following an international open call for applications, Martin Kampmann was among the 17 recipients of a Ben Barres Early Career Acceleration Award, which provides $2.5 million in research funding for each recipient. The Award is named for the late Ben Barres, eminent neurobiologist who was also openly transgender and a fierce advocate for young scientists, women, mentorship, and diversity in science. The Kampmann lab is developing and using CRISPR-based functional genomics approaches in neurons and glia derived from human induced pluripotent stem cells, in combination with cell biology and biochemistry, to uncover mechanisms and therapeutic targets for neurodegenerative diseases.
Read more on the Neurodegeneration Challenge Network and all funded investigators here.